These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 32522133)

  • 1. Symmetry of Disease in Retinopathy of Prematurity in the Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study.
    Lin LY; Jensen AK; Quinn GE; Spiller A; Tomlinson LA; Ying GS; Binenbaum G
    Ophthalmic Epidemiol; 2020 Dec; 27(6):477-481. PubMed ID: 32522133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and Early Course of Retinopathy of Prematurity: Secondary Analysis of the Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study.
    Quinn GE; Ying GS; Bell EF; Donohue PK; Morrison D; Tomlinson LA; Binenbaum G;
    JAMA Ophthalmol; 2018 Dec; 136(12):1383-1389. PubMed ID: 30326046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of non-type 1 retinopathy of prematurity in the Postnatal Growth and Retinopathy of Prematurity (G-ROP) study.
    Liu T; Tomlinson LA; Ying GS; Yang MB; Binenbaum G;
    J AAPOS; 2019 Dec; 23(6):332.e1-332.e6. PubMed ID: 31669723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the Postnatal Growth and Retinopathy of Prematurity Screening Criteria.
    Binenbaum G; Tomlinson LA; de Alba Campomanes AG; Bell EF; Donohue P; Morrison D; Quinn GE; Repka MX; Rogers D; Yang MB; Yu Y; Ying GS;
    JAMA Ophthalmol; 2020 Jan; 138(1):31-37. PubMed ID: 31725856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of Modified Screening Criteria for Retinopathy of Prematurity: Primary Results From the Postnatal Growth and Retinopathy of Prematurity Study.
    Binenbaum G; Bell EF; Donohue P; Quinn G; Shaffer J; Tomlinson LA; Ying GS;
    JAMA Ophthalmol; 2018 Sep; 136(9):1034-1040. PubMed ID: 30003216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of retinopathy of prematurity in fellow eyes in the cryotherapy for retinopathy of prematurity study. The Cryotherapy for Retinopathy of Prematurity Cooperative Group.
    Quinn GE; Dobson V; Biglan A; Evans J; Plotsky D; Hardy RJ
    Arch Ophthalmol; 1995 Apr; 113(4):469-73. PubMed ID: 7710397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the Children's Hospital of Philadelphia Retinopathy of Prematurity (CHOP ROP) Model.
    Binenbaum G; Ying GS; Tomlinson LA;
    JAMA Ophthalmol; 2017 Aug; 135(8):871-877. PubMed ID: 28715553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the Colorado Retinopathy of Prematurity Screening Model.
    McCourt EA; Ying GS; Lynch AM; Palestine AG; Wagner BD; Wymore E; Tomlinson LA; Binenbaum G;
    JAMA Ophthalmol; 2018 Apr; 136(4):409-416. PubMed ID: 29543944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perinatal Risk Factors for the Retinopathy of Prematurity in Postnatal Growth and Rop Study.
    Ying GS; Bell EF; Donohue P; Tomlinson LA; Binenbaum G;
    Ophthalmic Epidemiol; 2019 Aug; 26(4):270-278. PubMed ID: 31012360
    [No Abstract]   [Full Text] [Related]  

  • 10. Neonatal Intensive Care Unit-based screening program for retinopathy of prematurity and its treatment in an Indian population.
    Goyal A; Giridhar A; Gopalakrishnan M; Thachil T
    Indian J Ophthalmol; 2019 Jun; 67(6):828-833. PubMed ID: 31124496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraocular Hemorrhages and Retinopathy of Prematurity in the Telemedicine Approaches to Evaluating Acute-Phase Retinopathy of Prematurity (e-ROP) Study.
    Daniel E; Ying GS; Siatkowski RM; Pan W; Smith E; Quinn GE;
    Ophthalmology; 2017 Mar; 124(3):374-381. PubMed ID: 27986386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The outcome of retinopathy of prematurity: screening for retinopathy of prematurity using an outcome predictive program.
    Onofrey CB; Feuer WJ; Flynn JT
    Ophthalmology; 2001 Jan; 108(1):27-34; discussion 34-5. PubMed ID: 11150259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression of type 2 to type 1 retinopathy of prematurity in the Early Treatment for Retinopathy of Prematurity Study.
    Christiansen SP; Dobson V; Quinn GE; Good WV; Tung B; Hardy RJ; Baker JD; Hoffman RO; Reynolds JD; Rychwalski PJ; Shapiro MJ;
    Arch Ophthalmol; 2010 Apr; 128(4):461-5. PubMed ID: 20385942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postnatal Growth and Retinopathy of Prematurity Study: Rationale, Design, and Subject Characteristics.
    Binenbaum G; Tomlinson LA
    Ophthalmic Epidemiol; 2017 Feb; 24(1):36-47. PubMed ID: 27996334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes after Intravitreal Bevacizumab versus Laser Photocoagulation for Retinopathy of Prematurity: A 5-Year Retrospective Analysis.
    Hwang CK; Hubbard GB; Hutchinson AK; Lambert SR
    Ophthalmology; 2015 May; 122(5):1008-15. PubMed ID: 25687024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk analysis and an alternative protocol for reduction of screening for retinopathy of prematurity.
    Yang MB; Donovan EF
    J AAPOS; 2009 Dec; 13(6):539-45. PubMed ID: 20006812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of myopia at 9 months in infants with high-risk prethreshold retinopathy of prematurity.
    Davitt BV; Dobson V; Good WV; Hardy RJ; Quinn GE; Siatkowski RM; Summers CG; Tung B;
    Ophthalmology; 2005 Sep; 112(9):1564-8. PubMed ID: 16023214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinopathy of prematurity: are we missing any infant with retinopathy of prematurity?
    Amer M; Jafri WH; Nizami AM; Shomrani AI; Al-Dabaan AA; Rashid K
    Br J Ophthalmol; 2012 Aug; 96(8):1052-5. PubMed ID: 22649086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural history and outcomes of stage 3 retinopathy of prematurity persisting beyond 40 weeks of post-menstrual age: Dilemma for treatment and follow up.
    Koucheki R; Isaac M; N Tehrani N; Mireskandari K
    Clin Exp Ophthalmol; 2020 Sep; 48(7):956-963. PubMed ID: 32643860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular complications following treatment in the Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study.
    Morrison D; Shaffer J; Ying GS; Binenbaum G;
    J AAPOS; 2018 Apr; 22(2):128-133. PubMed ID: 29548840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.